Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Thadani
D M Roden

Circulation

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Circulation|June 25, 1998
FDA Panel report: January 1998U Thadani, D M Roden
Circulation|March 1, 1979
Propranolol in the treatment of angina pectoris. Comparison of duration of action in acute and sustained oral therapyU Thadani, J O Parker
Circulation|May 1, 1994
Mirror, mirror on the wall ... stereochemistry in therapeuticsD M Roden
Circulation|April 16, 1998
Cardiovascular and Renal Advisory Panel of the FDAD M Roden
Circulation|October 1, 1996
Ibutilide and the treatment of atrial arrhythmias. A new drug--almost unheralded--is now available to US physiciansD M Roden
Circulation|February 1, 1986
Pharmacologic information required for design of programmed electrical stimulation protocolsD M Roden
Circulation|February 1, 1980
Effects of low and high glucose in a glucose-insulin-potassium infusion on hemodynamics and exercise tolerance in patients with angina pectorisU Thadani, M A Chiong, J O Parker
Circulation|August 1, 1994
Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study GroupU Thadani, M Ezekowitz, L Fenney, et al.
Circulation|February 1, 1996
Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependenceT Yang, D M Roden
Circulation|March 1, 1980
Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrateU Thadani, D Manyari, J O Parker, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Circulation|June 25, 1998
FDA Panel report: January 1998U Thadani, D M Roden
Circulation|March 1, 1979
Propranolol in the treatment of angina pectoris. Comparison of duration of action in acute and sustained oral therapyU Thadani, J O Parker
Circulation|May 1, 1994
Mirror, mirror on the wall ... stereochemistry in therapeuticsD M Roden
Circulation|April 16, 1998
Cardiovascular and Renal Advisory Panel of the FDAD M Roden
Circulation|October 1, 1996
Ibutilide and the treatment of atrial arrhythmias. A new drug--almost unheralded--is now available to US physiciansD M Roden
Circulation|February 1, 1986
Pharmacologic information required for design of programmed electrical stimulation protocolsD M Roden
Circulation|February 1, 1980
Effects of low and high glucose in a glucose-insulin-potassium infusion on hemodynamics and exercise tolerance in patients with angina pectorisU Thadani, M A Chiong, J O Parker
Circulation|August 1, 1994
Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study GroupU Thadani, M Ezekowitz, L Fenney, et al.
Circulation|February 1, 1996
Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependenceT Yang, D M Roden
Circulation|March 1, 1980
Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrateU Thadani, D Manyari, J O Parker, et al.
Pageof 4